Jennifer A. Phipps - 04 Mar 2026 Form 4 Insider Report for BrightSpring Health Services, Inc. (BTSG)

Role
Chief Financial Officer
Signature
/s/ Jennifer Phipps
Issuer symbol
BTSG
Transactions as of
04 Mar 2026
Net transactions value
-$1,440,250
Form type
4
Filing time
06 Mar 2026, 19:45:12 UTC
Previous filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Phipps Jennifer A Chief Financial Officer C/O BRIGHTSPRING HEALTH SERVICES, INC., 805 N. WHITTINGTON PARKWAY, LOUISVILLE /s/ Jennifer Phipps 06 Mar 2026 0001891391

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTSG Common Stock Options Exercise +35,000 +18% $6.37* 231,840 04 Mar 2026 Direct
transaction BTSG Common Stock Sale $1,440,250 -35,000 -15% $41.15 196,840 04 Mar 2026 Direct F1
transaction BTSG Common Stock Award +53,384 +27% $0.000000* 250,224 05 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTSG Stock Options (Right to Buy) Award +35,331 +39% $0.000000* 125,708 04 Mar 2026 Common Stock 35,331 $6.37 Direct F3
transaction BTSG Stock Options (Right to Buy) Award +5,888 +33% $0.000000* 23,543 04 Mar 2026 Common Stock 5,888 $7.01 Direct F4
transaction BTSG Stock Options (Right to Buy) Options Exercise -35,000 -28% $0.000000* 90,708 04 Mar 2026 Common Stock 35,000 $6.37 Direct F5
transaction BTSG Stock Options (Right to Buy) Award +130,860 $0.000000* 130,860 05 Mar 2026 Common Stock 130,860 $41.77 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.
F2 On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement.
F3 No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested.
F4 No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested.
F5 These options are fully vested.
F6 Options vest in three equal annual installments commencing on January 25, 2027.